. What Are the Odds That Novavax’s Coronavirus Vaccine Is 90% Effective? « JO LEE MAGAZINE

The Motley Food – Last week, Pfizer  and BioNTech  announced positive results from the phase 3 trial for their coronavirus vaccine. The drug, BNT162b2, met all of the study’s primary and secondary endpoints, with an incredible 95% efficacy rate. Out of a subset of 8,000 volunteers, 162 people in the placebo group contracted COVID-19, and only eight people in the vaccinated group did.

Not to be outdone, Moderna…

More at The Motley Food

Comments are closed.